U.S. Behavioral Health Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

U.S. Behavioral Health Market Trends and Insights

Tightening Parity Enforcement Reshapes Reimbursement and Network Adequacy

State and federal parity enforcement is transforming compliance into a revenue-critical issue for the United States behavioral health market. In 2024 and 2025, Georgia imposed nearly USD 25 million in fines on 22 insurers for non-quantitative treatment limitations, while Washington fined Kaiser Foundation Health Plan USD 300,000, and Regence BlueShield and Premera Blue Cross USD 550,000 each for similar violations.^{[2]Center for Health Care Strategies, “Medicare Intensive Outpatient Program Coverage Update,” Center for Health Care Strategies, chcs.org} Payers are expanding provider networks and improving outpatient reimbursements to reduce regulatory scrutiny. Although the 2024 MHPAEA Final Rule adopted a federal non-enforcement stance in May 2025, states like Washington, Colorado, Maryland, and California incorporated its provisions into state laws, maintaining compliance expectations in major commercial markets.^{[3]Centers for Medicare & Medicaid Services, “Telehealth FAQ, February 2026,” CMS, cms.gov} This state-level adoption establishes a national baseline for access and documentation standards, ensuring providers who meet these criteria benefit from higher reimbursement quality.

Medicare and Medicaid Coverage Expansion Unlocking Access at Mid-Acuity Levels

Coverage expansions are addressing gaps in the United States behavioral health market, particularly for care levels between outpatient visits and inpatient services. Medicare began covering intensive outpatient program services on January 1, 2024, under the Consolidated Appropriations Act, 2023, enabling over 60 million beneficiaries to access reimbursable mid-acuity care. Geographic restrictions for behavioral health telehealth were permanently removed, allowing beneficiaries to receive care at home beyond the 2027 general telehealth deadline. Medicaid has also expanded Certified Community Behavioral Health Clinics from 67 facilities in 8 states in 2017 to over 500 across 46 states and the District of Columbia.^{[4]KFF, “Certified Community Behavioral Health Clinics and Medicaid Recognition, May 2026,” KFF, kff.org} By FY2025, 19 states recognized CCBHCs as Medicaid providers. The CMS ACCESS behavioral health model, launching in July 2026 with 85 behavioral health organizations and major payer alignment, strengthens outcome-linked payment systems and supports scalable mid-acuity care pathways.^{[5]Substance Abuse and Mental Health Services Administration, “Co-occurring Mental Illness and Substance Use Data, 2025,” SAMHSA, samhsa.gov}

Persistent Unmet Demand in Co-occurring Mental Health and SUD Conditions

Unmet demand for dual-diagnosis care remains a key growth driver in the United States behavioral health market. In 2024, 41.2% of the 21.2 million adults with both mental illness and substance use disorder received no treatment, and only 14.5% accessed integrated care. In January 2026, the White House reported 48.4 million Americans, or 16.8% of the population, had a substance use disorder, with 95.6% of untreated individuals perceiving no need for care. The stimulant-fentanyl fourth wave has intensified psychiatric complexities, with psychostimulant-related deaths rising from 3.9 to 10.4 per 100,000 people between 2018 and 2023, and stimulant use increasing 8.63% from 2021 to 2022. Providers with integrated clinical models are well-positioned to manage stepped care and attract higher-acuity, higher-reimbursing patient groups.

Sustained Tele-buprenorphine and Controlled-Substance Telehealth Prescribing

Tele-buprenorphine is enhancing medication access and retention in the United States behavioral health market, particularly in underserved areas. A VA cohort study linked telehealth use in buprenorphine treatment to a 52% lower risk of treatment discontinuation for opioid use disorder and a 54% lower risk for mental health conditions. A study in Oregon and Washington found telehealth-only buprenorphine treatment reduced discontinuation rates by 61% compared to office-based care. The DEA's Fourth Temporary Extension, issued in December 2025, allows telemedicine prescriptions for Schedule II to V controlled substances until December 31, 2026, without requiring prior in-person visits, benefiting approximately 5 million Americans with opioid use disorder. Policy variations across states, rather than clinical evidence, remain the primary barrier to equitable access. Organizations capable of scaling compliant virtual medication pathways in underserved regions are well-positioned to address these gaps.

Workforce Shortages and Low Public-Payer Reimbursement Rates

Workforce shortages remain a significant barrier in the United States behavioral health market. By December 2025, 137 million Americans, or 40% of the population, lived in federally designated mental health professional shortage areas, with the number of such designations increasing from 6,418 in 2024 to 6,807 in 2026. By 2038, projected shortfalls include 99,840 mental health counselors, 99,840 psychologists, 77,050 addiction counselors, and 36,780 adult psychiatrists. The supply of psychiatrists is expected to decline from 37,470 in 2026 to 36,550 in 2038, even as annual demand rises by 40.7%. Rural areas face significant access challenges, with rural counties nearly three times more likely than urban ones to lack psychologists, and 22% of rural counties reporting no clinical social workers. 

Ghost Networks, Prior Authorization Friction, and Utilization Management Barriers

Administrative challenges continue to hinder demand in the United States behavioral health market. In 2025, a review revealed that 55% of behavioral health providers listed under Medicare Advantage were inactive in 2023, while 28% of Medicaid managed care providers were also inactive. In rural counties, the Medicare Advantage inactive provider rate reached 63%, with 72% of these providers erroneously listed. Of these, 46% had retired or left practice, and 21% had never contracted with the plan. Prior authorization requirements further complicate access, as reauthorization is often needed every 8 to 20 sessions, consuming 5% to 10% of session revenue.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Treatment Modality: Telehealth Redefining the Ambulatory Channel

In 2025, ambulatory visits accounted for 41.10% of the United States behavioral health market, leading as care shifted toward outpatient and virtual settings. Behavioral health made up 65.6% of all United States telehealth visits in 2024, a significant rise from 18.4% in 2018. Total behavioral health telehealth visits reached 66.4 million, surpassing the 62.8 million primary care telehealth visits during the same period. This shift highlights telehealth's evolution into a standard delivery channel for routine therapy, medication management, and follow-ups.

Prescription medicines are the fastest-growing treatment modality, with the United States behavioral health market for this segment projected to grow at a 5.25% CAGR from 2026 to 2031. Stimulant prescriptions rose by 53.3% between 2018 and 2024, while antipsychotic volumes increased by 45.4%. Nurse practitioners and physician assistants managed 34.3% of prescription volume in 2024, surpassing psychiatrists and primary care physicians.

By Condition Group: Co-occurring Conditions Outgrow the Largest Segment

Mental health conditions held a 72.2% share in 2025, making them the largest condition group in the United States behavioral health market. Anxiety disorders led telehealth use among Medicare beneficiaries in 2024, with 9.45 million visits, followed by 8.77 million visits for depressive disorders. Substance use disorders remain smaller but are growing due to contingency management programs supported by Medicaid Section 1115 waivers in several states. Co-occurring conditions are the fastest-growing segment, with a projected 5.95% CAGR from 2026 to 2031. A 2026 study demonstrated that integrated buprenorphine and psychotherapy significantly improved remission rates, reinforcing the value of combined care for dual-diagnosis populations.

By Site of Care: PHP and IOP Emerging as the Market's Structural Inflection Point

Outpatient clinics and office-based care represented 57.45% of the United States behavioral health market in 2025, reflecting a shift from inpatient infrastructure to flexible, cost-effective settings. Residential treatment centers and inpatient psychiatric hospitals remain essential for high-acuity cases but face challenges like high labor costs and limited growth potential. PHPs and IOPs are the fastest-growing site category, with a forecasted 6.86% CAGR through 2031. Medicare's IOP coverage expansion in January 2024 created a reimbursable care level for 60 million beneficiaries. Virtual IOPs have shown to reduce readmission rates to 4% or less, compared to national psychiatric readmission rates exceeding 20% within six months.

By Age Cohort: Adolescent Surge Creates a Distinct Clinical Submarket

Adults accounted for 69.66% of the United States behavioral health market in 2025, remaining the largest age cohort across conditions, modalities, and care sites. Medicaid and CHIP play a critical role, covering nearly 50% of adults with opioid use disorder. Policy changes directly impact visit volumes, medication access, and provider participation for this group. Adolescents are the fastest-growing cohort, with a projected 6.67% CAGR from 2026 to 2031. In 2025, 51% of 97,000 youth screened for depression reported frequent suicidal ideation, the highest rate since 2014. Diagnosed anxiety disorders among adolescents aged 12 to 17 rose by 61% from 2016 to 2023. Telehealth has proven effective in narrowing access gaps, with outcomes for high-risk adolescents comparable to their lower-risk peers after 12 sessions.

Geography Analysis

Long-established academic medical infrastructure and a higher psychiatrist density than the national average position the Northeast as the most densely served region in the United States behavioral health market. Massachusetts has 41.34 psychiatrists per 100,000 residents, followed by Rhode Island at 37.94, Connecticut at 35.59, and New York at 35.02, compared to the national average of 18.26 per 100,000. Telehealth usage is also high, with 17.8% of urban patients making telehealth claims in December 2025, compared to 12.2% in rural areas. New York's behavioral health access standard, implemented in July 2025, requires care within 10 days, increasing pressure on payers and networks to expedite services. Despite these advantages, in-network access challenges persist, as highlighted by a 2025 lawsuit against Carelon Behavioral Health, which revealed ghost rates of 73% to 94% across several counties.

The South faces significant access gaps in the United States behavioral health market relative to its population needs. Mississippi has 9.85 psychiatrists per 100,000 residents, Alabama 10.59, and Tennessee 10.82, while rural suicide rates in 2023 were 20.2 per 100,000 compared to 13.8 in urban areas. Texas and Florida, despite large provider pools, still face practitioner shortages of 606 and 545, respectively, as per HRSA estimates. The fragility of safety-net systems is evident from Arisa Health's 2026 exit from its 41-county community mental health center contract in Arkansas following a USD 4.4 million funding cut. Telehealth adoption for mental health is growing rapidly, with psychotherapy leading telehealth procedure categories, offering a scalable solution to address workforce shortages.